Cosmetic cross-reference Noindex: medium evidence

992-78-9

CAS 992-78-9

992-78-9 (CAS 992-78-9) is a pharmaceutical compound with 0 bioactivity targets and 225 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
0
SOURCE DrugCentral
Adverse signals
225
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
992-78-9
CAS Number
992-78-9
UNII
M9NL0C577Y
InChIKey
QNTNKSLOFHEFPK-UPTCCGCDSA-N
ChEMBL ID
CHEMBL5272956
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
natural product
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is 992-78-9 used for in pharmaceutical contexts?

992-78-9 (CAS 992-78-9) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for 992-78-9?

992-78-9 has 225 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Abdominal discomfort, Abdominal pain, Abnormal dreams, Allergy to synthetic fabric, Anxiety. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is 992-78-9 also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Ubiquinol with EU status "permitted".

What clinical phase is 992-78-9 in?

No phase 1-4 clinical development badge is rendered for 992-78-9 because the matched compound identifier rows do not contain a max-phase value.